Cell population heterogeneity and evolution towards drug resistance in cancer: Biological and mathematical assessment, theoretical treatment optimisation
- 1 November 2016
- journal article
- review article
- Published by Elsevier BV in Biochimica et Biophysica Acta (BBA) - General Subjects
- Vol. 1860 (11), 2627-2645
- https://doi.org/10.1016/j.bbagen.2016.06.009
Abstract
No abstract availableKeywords
This publication has 100 references indexed in Scilit:
- The contribution of age structure to cell population responses to targeted therapeuticsJournal of Theoretical Biology, 2012
- Role of intratumoural heterogeneity in cancer drug resistance: molecular and clinical perspectivesEMBO Molecular Medicine, 2012
- Bistability, Bifurcations, and Waddington's Epigenetic LandscapeCurrent Biology, 2012
- Epigenetic mechanisms in tumorigenesis, tumor cell heterogeneity and drug resistanceDrug Resistance Updates, 2012
- Role of TET2 Mutations in Myeloproliferative NeoplasmsCurrent Hematologic Malignancy Reports, 2011
- Cellular Heterogeneity: Do Differences Make a Difference?Cell, 2010
- Tracing the tumor lineageMolecular Oncology, 2010
- A Chromatin-Mediated Reversible Drug-Tolerant State in Cancer Cell SubpopulationsCell, 2010
- Epithelial-Mesenchymal Transitions in Development and DiseaseCell, 2009
- Induction of Pluripotent Stem Cells from Mouse Embryonic and Adult Fibroblast Cultures by Defined FactorsCell, 2006